new lung cancer drug opdivo nivolumab

Keyword Analysis

Keyword	CPC	PCC	Volume	Score	Length of keyword
new lung cancer drug opdivo nivolumab	0.17	0.5	4280	49	37
new	0.91	0.8	1192	93	3
lung	1.67	0.2	1594	25	4
cancer	1.13	0.6	1706	85	6
drug	1.47	0.9	2653	28	4
opdivo	1.99	0.1	4371	19	6
nivolumab	0.31	0.9	6480	30	9

Keyword	CPC	PCC	Volume	Score
new lung cancer drug opdivo nivolumab	0.65	0.7	8979	79
new lung cancer drug opdivo	1.33	0.5	6935	40
new lung cancer drug opdivo availability	1.59	0.3	1854	36
new lung cancer drug opdivo reviews	1.88	0.5	4495	59
new lung cancer drug opdivo clinical trials	0.56	0.4	2806	1
new lung cancer drug opdivo results	0.49	0.2	3115	20
new lung cancer drug opdivo approval	0.02	0.2	2988	62
new lung cancer drug opdivo fda approval	1.67	1	5593	16
new lung cancer drug opdivo manufacturer	1.86	1	1649	46
new lung cancer drug opdivo and yervoy	1.04	0.9	8713	6
new lung cancer drug opdivo dosage	1.63	1	9582	32
new lung cancer drug opdivo survival rates	1.25	0.4	108	42
lung cancer chemo drug nivolumab	0.52	0.2	279	60
neoadjuvant opdivo for lung cancer	0.56	0.3	5522	5
nivolumab neoadjuvant lung cancer	1.89	0.6	8213	78
opdivo immunotherapy for lung cancer nhs	1.26	0.9	8389	53
opdivo immunotherapy for lung cancer	0.81	0.7	3289	34
nivolumab for lung cancer	0.71	1	8767	45
opdivo for lung cancer	0.14	0.2	8876	53
opdivo treatment for lung cancer	1.78	0.3	4033	80
opdivo small cell lung cancer fda	1.75	0.4	162	21